VTV THERAPEUTICS INC. Item 5.07 Submission of Matters to a Vote of Security Holders
On
(1) The Company's stockholders elected the nominees listed below to the
Company's Board of Directors, each to serve for a term to expire at the
Company's 2021 annual meeting of stockholders or until their successors
are duly elected and qualified based on the following results of the
voting:
Director Nominee For Against Withheld Broker Non-Votes
Jeffrey B. Kindler 59,531,174 - 150,874 5,947,754
John A. Fry 59,593,955 - 88,093 5,947,754
Hersh Kozlov 59,543,228 - 138,820 5,947,754
Paul G. Savas 59,556,857 - 125,191 5,947,754
Noel J. Spiegel 59,603,564 - 78,484 5,947,754
Howard L. Weiner 59,602,155 - 79,893 5,947,754
(2) An amendment to the Company's 2015 Omnibus Equity Incentive Plan (the
"Omnibus Incentive Plan") to increase the number of authorized shares
reserved for issuance under the Omnibus Incentive Plan was approved
based on the following results of the voting:
For Against Withheld Broker Non-Votes
59,156,032 454,594 71,422 5,947,754
(3) The appointment of Ernst & Young LLP as our independent registered
public accounting firm for the fiscal year ending December 31, 2020 was
ratified based on the following results of the voting:
For Against Abstain
65,258,211 328,705 42,886
--------------------------------------------------------------------------------
© Edgar Online, source
